Overwijk WW - Search Results

1

Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells.

Bronte V, Wang M, Overwijk WW, Surman DR, Pericle F, Rosenberg SA, Restifo NP. Bronte V, et al. Among authors: overwijk ww. J Immunol. 1998 Nov 15;161(10):5313-20. J Immunol. 1998. PMID: 9820504 Free PMC article.

2

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, Rosenberg SA, Restifo NP. Antony PA, et al. Among authors: overwijk ww. J Immunol. 2005 Mar 1;174(5):2591-601. doi: 10.4049/jimmunol.174.5.2591. J Immunol. 2005. PMID: 15728465 Free PMC article.

3

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.

Bronte V, Carroll MW, Goletz TJ, Wang M, Overwijk WW, Marincola F, Rosenberg SA, Moss B, Restifo NP. Bronte V, et al. Among authors: overwijk ww. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3183-8. doi: 10.1073/pnas.94.7.3183. Proc Natl Acad Sci U S A. 1997. PMID: 9096367 Free PMC article.

4

Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigens.

Overwijk WW, Surman DR, Tsung K, Restifo NP. Overwijk WW, et al. Methods. 1997 Jun;12(2):117-23. doi: 10.1006/meth.1997.0461. Methods. 1997. PMID: 9184376

5

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.

Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, Tsung K, Carroll MW, Liu C, Moss B, Rosenberg SA, Restifo NP. Overwijk WW, et al. J Exp Med. 1998 Jul 20;188(2):277-86. doi: 10.1084/jem.188.2.277. J Exp Med. 1998. PMID: 9670040 Free PMC article.

6

Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen.

Carroll MW, Overwijk WW, Surman DR, Tsung K, Moss B, Restifo NP. Carroll MW, et al. Among authors: overwijk ww. J Natl Cancer Inst. 1998 Dec 16;90(24):1881-7. doi: 10.1093/jnci/90.24.1881. J Natl Cancer Inst. 1998. PMID: 9862625 Free PMC article.

7

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, Carroll MW, Moss B, Rosenberg SA, Restifo NP. Overwijk WW, et al. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2982-7. doi: 10.1073/pnas.96.6.2982. Proc Natl Acad Sci U S A. 1999. PMID: 10077623 Free PMC article.

8

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen.

Surman DR, Dudley ME, Overwijk WW, Restifo NP. Surman DR, et al. Among authors: overwijk ww. J Immunol. 2000 Jan 15;164(2):562-5. doi: 10.4049/jimmunol.164.2.562. J Immunol. 2000. PMID: 10623795 Free PMC article.

9

Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.

Bronte V, Apolloni E, Ronca R, Zamboni P, Overwijk WW, Surman DR, Restifo NP, Zanovello P. Bronte V, et al. Among authors: overwijk ww. Cancer Res. 2000 Jan 15;60(2):253-8. Cancer Res. 2000. PMID: 10667570 Free PMC article.

10

The future of interleukin-2: enhancing therapeutic anticancer vaccines.

Overwijk WW, Theoret MR, Restifo NP. Overwijk WW, et al. Cancer J Sci Am. 2000 Feb;6 Suppl 1(Suppl 1):S76-80. Cancer J Sci Am. 2000. PMID: 10685664 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters